Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
For full access to this article login to GEN Select now.
Nanotechnology Draws Closer to a Clinical Debut
T-Cell Based Delivery Systems and New Imaging Options Push Field Forward
- Nanotechnology is combining with T-cell biology to produce diagnostics and therapeutics that evade the immune system and deliver localized therapeutic payloads, which, through their tight targeting, minimize adverse side effects. At TechConnect World’s recent “Nanotech” conference and expo in Anaheim, industry and academic researchers elaborated on the advances ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.